Seelos Therapeutics, Inc. (SEEL) Earnings
|
Expand Research on SEEL
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +14.8% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | 0.0% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 3/1/24 | Q423 | N/A | -$0.06 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/20/23 | Q323 | N/A | -$0.08 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/13/23 | Q323 | N/A | -$0.06 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/6/23 | Q323 | N/A | -$0.06 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/3/23 | Q323 | N/A | -$0.06 | N/A | N/A | $150K | N/A | N/A | N/A | ||
| 11/27/23 | Q323 | N/A | -$0.08 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/7/23 | Q223 | N/A | -$0.09 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/4/23 | Q223 | N/A | -$0.09 | N/A | N/A | N/A | N/A | N/A | N/A |
